used in classic Chinese, Ayurvedic, and Thai medication. Conolidine could represent the start of a new era of Long-term pain administration. It is currently getting investigated for its outcomes to the atypical chemokine receptor (ACK3). Inside a rat design, it was found that a competitor molecule binding to ACKR3 resulted in inhibition of ACKR3’